4.01
price down icon8.66%   -0.38
after-market After Hours: 4.02 0.010 +0.25%
loading
Scilex Holding Company stock is traded at $4.01, with a volume of 185.29K. It is down -8.66% in the last 24 hours and down -51.66% over the past month. Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
See More
Previous Close:
$4.39
Open:
$4.38
24h Volume:
185.29K
Relative Volume:
2.10
Market Cap:
$28.48M
Revenue:
$46.74M
Net Income/Loss:
$-114.33M
P/E Ratio:
-3.1085
EPS:
-1.29
Net Cash Flow:
$-21.04M
1W Performance:
-26.29%
1M Performance:
-51.66%
6M Performance:
-86.98%
1Y Performance:
-86.20%
1-Day Range:
Value
$3.95
$4.54
1-Week Range:
Value
$3.95
$6.1314
52-Week Range:
Value
$3.60
$80.50

Scilex Holding Company Stock (SCLX) Company Profile

Name
Name
Scilex Holding Company
Name
Phone
(650) 516-4310
Name
Address
960 SAN ANTONIO ROAD, PALO ALTO
Name
Employee
115
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
SCLX's Discussions on Twitter

Compare SCLX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - General icon
SCLX
Scilex Holding Company
4.01 28.48M 46.74M -114.33M -21.04M -1.29
Drug Manufacturers - General icon
LLY
Lilly Eli Co
734.57 739.39B 49.00B 11.11B -1.27B 12.29
Drug Manufacturers - General icon
JNJ
Johnson Johnson
154.22 375.64B 89.33B 21.81B 18.57B 8.99
Drug Manufacturers - General icon
ABBV
Abbvie Inc
184.60 351.09B 57.37B 4.20B 17.83B 2.35
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
65.77 307.32B 43.59B 15.04B 10.74B 3.3766
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
108.70 225.73B 53.22B 12.86B 14.85B 6.39

Scilex Holding Company Stock (SCLX) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-27-25 Initiated D. Boral Capital Buy
Oct-16-24 Initiated Alliance Global Partners Buy
Jun-13-24 Initiated Rodman & Renshaw Buy
Oct-16-23 Initiated B. Riley Securities Buy
Oct-13-23 Initiated B. Riley Securities Buy
Oct-09-23 Initiated H.C. Wainwright Buy
View All

Scilex Holding Company Stock (SCLX) Latest News

pulisher
May 09, 2025

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination - The Manila Times

May 09, 2025
pulisher
May 01, 2025

Scilex Holding Company to Present Post-Hoc Analysis of the C.L.E.A.R. Trial on Clinical Meaningfulness of Safety and Efficacy of SP-102 for the Treatment of Lumbosacral Radicular Pain (LRP) at the 27th Annual Meeting of American Society of Interventional - GlobeNewswire

May 01, 2025
pulisher
Apr 30, 2025

Scilex Regains Compliance With Nasdaq Listing Rule; Shares Rise - marketscreener.com

Apr 30, 2025
pulisher
Apr 30, 2025

Scilex Holding Company Regains Compliance with Nasdaq Minimum Closing Bid Price Requirement - Nasdaq

Apr 30, 2025
pulisher
Apr 30, 2025

Scilex Holding Company Regains Compliance with NASDAQ Minimum Bid Price Rule - GlobeNewswire

Apr 30, 2025
pulisher
Apr 30, 2025

Scilex Holding Company’s Market Journey: Closing Weak at 0.24, Down -2.01 - DWinneX

Apr 30, 2025
pulisher
Apr 22, 2025

Scilex Adjusts Record Date for Preferred Stock Dividend - TipRanks

Apr 22, 2025
pulisher
Apr 22, 2025

Scilex Holding Company Announces New Record Date for Preferred Stock Dividend - Nasdaq

Apr 22, 2025
pulisher
Apr 22, 2025

Scilex Holding Company Announces Change in Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex's Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from April 11, 202 - The Manila Times

Apr 22, 2025
pulisher
Apr 22, 2025

Scilex Holding Company Announces Change in Record Date for - GlobeNewswire

Apr 22, 2025
pulisher
Apr 22, 2025

Scilex Holding Company Announces Change in Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from April 11, 202 - Yahoo Finance

Apr 22, 2025
pulisher
Apr 21, 2025

Scilex Holding Amends Merger Agreement with Denali By Investing.com - Investing.com Canada

Apr 21, 2025
pulisher
Apr 21, 2025

Scilex Holding Amends Merger Agreement with Denali - Investing.com Australia

Apr 21, 2025
pulisher
Apr 20, 2025

Scilex Holding Company announces completion of commercial manufacturing of Gloperba® with the brand marketed and distributed under Scilex Pharmaceuticals, Inc. and is expecting to Launch in the U.S. in the first quarter of 2024 - Seeking Alpha

Apr 20, 2025
pulisher
Apr 17, 2025

Scilex Holding Company Announces FDA Has Approved Our Request for the Orphan Drug Designation for Colchicine for the Treatment of Pericarditis - The Manila Times

Apr 17, 2025
pulisher
Apr 16, 2025

Scilex Gets FDA Orphan Drug Label for Colchicine for Pericarditis - marketscreener.com

Apr 16, 2025
pulisher
Apr 16, 2025

Scilex Gets Orphan Drug Designation for Its Version of Colchicine - marketscreener.com

Apr 16, 2025
pulisher
Apr 16, 2025

Scilex Holding Company Announces FDA Has Approved Our - GlobeNewswire

Apr 16, 2025
pulisher
Apr 16, 2025

[Reporter’s Notebook] Is NeuroBiogen’s tisolagiline really worth $4.5 billion? - koreabiomed.com

Apr 16, 2025
pulisher
Apr 15, 2025

Scilex Holding announces 1-for-35 reverse stock split By Investing.com - Investing.com Canada

Apr 15, 2025
pulisher
Apr 15, 2025

What Does the Market Think About Scilex Holding? - Benzinga

Apr 15, 2025
pulisher
Apr 15, 2025

Scilex Holding announces 1-for-35 reverse stock split - Investing.com Australia

Apr 15, 2025
pulisher
Apr 15, 2025

Canada approves Scilex’s migraine solution ELYXYB - Investing.com

Apr 15, 2025
pulisher
Apr 15, 2025

Scilex Holding Company Announces Approval of a New Drug - GlobeNewswire

Apr 15, 2025
pulisher
Apr 15, 2025

Scilex Holding Company Announces Approval of a New Drug Submission (NDS) from the Health Canada’s Pharmaceutical Drugs Directorate, Bureau of Cardiology, Allergy and Neurological Sciences for ELYXYB®’s Acute Treatment of Migraine With or Witho - Yahoo Finance

Apr 15, 2025
pulisher
Apr 14, 2025

Denali Capital Acquisition Corp. Announces Shareholder Approval of Extension of Deadline to Complete Business Combination - GlobeNewswire Inc.

Apr 14, 2025
pulisher
Apr 14, 2025

Scilex’s (SCLX) Hold Rating Reiterated at D. Boral Capital - Defense World

Apr 14, 2025
pulisher
Apr 12, 2025

Scilex downgraded to Hold from Buy at D. Boral Capital - Yahoo Finance

Apr 12, 2025
pulisher
Apr 11, 2025

Scilex to Implement 1-for-35 Reverse Stock Split - marketscreener.com

Apr 11, 2025
pulisher
Apr 11, 2025

Scilex Announces Reverse Stock Split to Meet Nasdaq Rules - TipRanks

Apr 11, 2025
pulisher
Apr 11, 2025

Scilex Holding Company Announces 1-For-35 Reverse Stock Split - marketscreener.com

Apr 11, 2025
pulisher
Apr 11, 2025

Scilex Holding Company Announces 1-for-35 Reverse Stock Split - GlobeNewswire

Apr 11, 2025
pulisher
Apr 11, 2025

Scilex (SCLX) Downgraded to Hold Following Reverse Stock Split Announcement | SCLX Stock News - GuruFocus

Apr 11, 2025
pulisher
Apr 04, 2025

D. Boral Capital Has Lowered Expectations for Scilex (NASDAQ:SCLX) Stock Price - Defense World

Apr 04, 2025
pulisher
Mar 31, 2025

Is Scilex Holding Company (NASDAQ: SCLX) Still A Good Investment? - stocksregister.com

Mar 31, 2025
pulisher
Mar 31, 2025

Scilex Holding Company (SCLX) reports earnings - qz.com

Mar 31, 2025
pulisher
Mar 27, 2025

Scilex (NASDAQ:SCLX) Stock Price Up 1.8% – Here’s What Happened - Defense World

Mar 27, 2025
pulisher
Mar 26, 2025

Scilex Holding Company Has Appealed Lower Court Decision to - GlobeNewswire

Mar 26, 2025
pulisher
Mar 26, 2025

Scilex Holding Company Has Appealed Lower Court Decision to the U.S. Court of Appeals for the Federal Circuit in Washington, DC and Will Continue to Vigorously Pursue its Infringement Action Against Aveva - The Manila Times

Mar 26, 2025
pulisher
Mar 19, 2025

Hogs Weakness Extending to Wednesday - The Globe and Mail

Mar 19, 2025
pulisher
Mar 17, 2025

AUDNZD Finally Turning Bearish? - The Globe and Mail

Mar 17, 2025
pulisher
Mar 12, 2025

Denali Capital Acquisition Pushes Merger Deadline With Extra Funding -March 12, 2025 at 04:44 am EDT - Marketscreener.com

Mar 12, 2025
pulisher
Mar 10, 2025

Scilex Announces New Record Date for Preferred Stock - TipRanks

Mar 10, 2025
pulisher
Mar 10, 2025

Scilex Holding Company Announces Change in Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex's Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from January 28, - The Manila Times

Mar 10, 2025
pulisher
Mar 10, 2025

Scilex Holding Company Announces Change of Record Date for Preferred Stock Dividend - Nasdaq

Mar 10, 2025
pulisher
Mar 10, 2025

Scilex Holding Company Announces Change in Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from January 28, - Yahoo Finance

Mar 10, 2025
pulisher
Mar 05, 2025

Scilex Holding Ends Sales Agreement with Brokers - TipRanks

Mar 05, 2025
pulisher
Mar 04, 2025

Oramed Pharmaceuticals Issues Letter to Shareholders – Company Announcement - Financial Times

Mar 04, 2025
pulisher
Mar 04, 2025

Scilex Holding Company (NASDAQ:SCLX) Stock's 29% Dive Might Signal An Opportunity But It Requires Some Scrutiny - Simply Wall St

Mar 04, 2025
pulisher
Mar 04, 2025

Breakeven Is Near for Scilex Holding Company (NASDAQ:SCLX) - Yahoo Canada Finance

Mar 04, 2025
pulisher
Mar 03, 2025

Scilex Holding ends sales agreement, shares details By Investing.com - Investing.com Australia

Mar 03, 2025

Scilex Holding Company Stock (SCLX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$96.91
price down icon 1.27%
drug_manufacturers_general SNY
$49.90
price down icon 4.28%
drug_manufacturers_general PFE
$22.28
price down icon 3.00%
$265.86
price down icon 2.28%
drug_manufacturers_general MRK
$75.97
price down icon 2.16%
drug_manufacturers_general NVS
$108.70
price down icon 1.30%
Cap:     |  Volume (24h):